Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9194)
All Articles published online
|
Publishing Process of This Article
|
Aug 14, 2014 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mohelnikova-Duchonova B, Melichar B, Soucek P. FOLFOX/FOLFIRI pharmacogenetics: The call for a personalized approach in colorectal cancer therapy. World J Gastroenterol 2014; 20(30): 10316-10330 [PMID: 25132748 DOI: 10.3748/wjg.v20.i30.10316] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i30/10316.htm |
| Number | Citing Articles |
| 1 |
Marta Pellicer, Xandra García-González, María I García, Carolina Blanco, Pilar García-Alfonso, Luis Robles, Cristina Grávalos, Daniel Rueda, Joaquín Martínez, Vanessa Pachón, Federico Longo, Virginia Martínez, Irene Iglesias, Sara Salvador, María Sanjurjo, Luis A López-Fernández. Use of exome sequencing to determine the full profile of genetic variants in the fluoropyrimidine pathway in colorectal cancer patients affected by severe toxicity. Pharmacogenomics 2017; 18(13): 1215 doi: 10.2217/pgs-2017-0118
|
| 2 |
Julita Kulbacka, Kazimiera A. Wilk, Urszula Bazylińska, Magda Dubińska-Magiera, Stanisław Potoczek, Jolanta Saczko. Curcumin Loaded Nanocarriers with Varying Charges Augmented with Electroporation Designed for Colon Cancer Therapy. International Journal of Molecular Sciences 2022; 23(3): 1377 doi: 10.3390/ijms23031377
|
| 3 |
Mei Jing Piao, Xia Han, Kyoung Ah Kang, Pincha Devage Sameera Madushan Fernando, Herath Mudiyanselage Udari Lakmini Herath, Jin Won Hyun. The Endoplasmic Reticulum Stress Response Mediates Shikonin-Induced Apoptosis of 5-Fluorouracil-Resistant Colorectal Cancer Cells. Biomolecules & Therapeutics 2022; 30(3): 265 doi: 10.4062/biomolther.2021.118
|
| 4 |
Vlasta Korenkova, Jana Slyskova, Vendula Novosadova, Sara Pizzamiglio, Lucie Langerova, Jens Bjorkman, Ondrej Vycital, Vaclav Liska, Miroslav Levy, Karel Veskrna, Pavel Vodicka, Ludmila Vodickova, Mikael Kubista, Paolo Verderio. The focus on sample quality: Influence of colon tissue collection on reliability of qPCR data. Scientific Reports 2016; 6(1) doi: 10.1038/srep29023
|
| 5 |
Davis A. Englund, Alyssa M. Jolliffe, Gabriel J. Hanson, Zaira Aversa, Xu Zhang, Xinyi Jiang, Thomas A. White, Lei Zhang, David G. Monroe, Paul D. Robbins, Laura J. Niedernhofer, Theodore M. Kamenecka, Sundeep Khosla, Nathan K. LeBrasseur. Senotherapeutic drug treatment ameliorates chemotherapy-induced cachexia. JCI Insight 2024; 9(2) doi: 10.1172/jci.insight.169512
|
| 6 |
Yingfang Fan, Najia Mansoor, Tasneem Ahmad, Zhuo X. Wu, Rafeeq A. Khan, Martin Czejka, Syed Sharib, Mansoor Ahmed, Zhe S. Chen, Dong H. Yang. Enzyme and Transporter Kinetics for CPT-11 (Irinotecan) and SN-38: An Insight on Tumor Tissue Compartment Pharmacokinetics Using PBPK. Recent Patents on Anti-Cancer Drug Discovery 2019; 14(2): 177 doi: 10.2174/1574892814666190212164356
|
| 7 |
Mohammad Azhar Aziz, Zeyad Yousef, Ayman M. Saleh, Sameer Mohammad, Bandar Al Knawy. Towards personalized medicine of colorectal cancer. Critical Reviews in Oncology/Hematology 2017; 118: 70 doi: 10.1016/j.critrevonc.2017.08.007
|
| 8 |
Tianqi Dong, Yuncang Yuan, Xudong Xiang, Shuping Sang, Hao Shen, Lei Wang, Chunyan Yang, Fangfang Li, Hongliang Li, Shangyong Zheng. High cytoplasmic YAP1 expression predicts a poor prognosis in patients with colorectal cancer. PeerJ 2020; 8: e10397 doi: 10.7717/peerj.10397
|
| 9 |
Octav Ginghina, Ariana Hudita, Marius Zamfir, Andrada Spanu, Mara Mardare, Irina Bondoc, Laura Buburuzan, Sergiu Emil Georgescu, Marieta Costache, Carolina Negrei, Cornelia Nitipir, Bianca Galateanu. Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies: A Modern Approach in Patient’s Stratification. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.856575
|
| 10 |
Lavinia Luput, Alina Sesarman, Alina Porfire, Marcela Achim, Dana Muntean, Tibor Casian, Laura Patras, Valentin Florian Rauca, Denise Minerva Drotar, Ioana Stejerean, Ioan Tomuta, Laurian Vlase, Nicolae Dragos, Vlad Alexandru Toma, Emilia Licarete, Manuela Banciu. Liposomal simvastatin sensitizes C26 murine colon carcinoma to the antitumor effects of liposomal 5‐fluorouracil in vivo. Cancer Science 2020; 111(4): 1344 doi: 10.1111/cas.14312
|
| 11 |
Juste Maneikyte, Augustinas Bausys, Bettina Leber, Nicole Feldbacher, Gerald Hoefler, Dagmar Kolb-Lenz, Kestutis Strupas, Philipp Stiegler, Peter Schemmer. Dietary Glycine Prevents FOLFOX Chemotherapy-Induced Heart Injury: A Colorectal Cancer Liver Metastasis Treatment Model in Rats. Nutrients 2020; 12(9): 2634 doi: 10.3390/nu12092634
|
| 12 |
Ninon Very, Tony Lefebvre, Ikram El Yazidi-Belkoura. Drug resistance related to aberrant glycosylation in colorectal cancer. Oncotarget 2018; 9(1): 1380 doi: 10.18632/oncotarget.22377
|
| 13 |
Iago Dillion Lima Cavalcanti. Chemotherapy Protocols and Infusion Sequence. 2022; : 27 doi: 10.1007/978-3-031-10839-6_2
|
| 14 |
Viktor Hlavac, Radka Vaclavikova, Veronika Brynychova, Pavel Dvorak, Katerina Elsnerova, Renata Kozevnikovova, Karel Raus, Katerina Kopeckova, Sona Mestakova, David Vrana, Jiri Gatek, Pavel Soucek. SLC46A1 Haplotype with Predicted Functional Impact has Prognostic Value in Breast Carcinoma. Molecular Diagnosis & Therapy 2021; 25(1): 99 doi: 10.1007/s40291-020-00506-2
|
| 15 |
Jacopo Junio Valerio Branca, Donatello Carrino, Massimo Gulisano, Carla Ghelardini, Lorenzo Di Cesare Mannelli, Alessandra Pacini. Oxaliplatin-Induced Neuropathy: Genetic and Epigenetic Profile to Better Understand How to Ameliorate This Side Effect. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.643824
|
| 16 |
Rafael Barreto, Yukiko Kitase, Tsutomu Matsumoto, Fabrizio Pin, Kyra C. Colston, Katherine E. Couch, Thomas M. O’Connell, Marion E. Couch, Lynda F. Bonewald, Andrea Bonetto. ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-15040-1
|
| 17 |
Athanasios Patsalias, Zuzana Kozovska. Personalized medicine: Stem cells in colorectal cancer treatment. Biomedicine & Pharmacotherapy 2021; 141: 111821 doi: 10.1016/j.biopha.2021.111821
|
| 18 |
Hemant Devidas Une, Mrudula Yogesh Kumavat, Amar Bhagwan Shirsat. Role of Lactobacillus and calcium in colorectal cancer. Indian Journal of Pathology and Oncology 2023; 10(3): 224 doi: 10.18231/j.ijpo.2023.051
|
| 19 |
Marie Bartouskova, Bohuslav Melichar, Beatrice Mohelnikova-Duchonova. Folate receptor: a potential target in ovarian cancer. Pteridines 2015; 26(1): 1 doi: 10.1515/pterid-2014-0013
|
| 20 |
Reza Negarandeh, Ebrahim Salehifar, Fatemeh Saghafi, Hossein Jalali, Ghasem Janbabaei, Mohammad Javad Abdhaghighi, Anahita Nosrati. Evaluation of adverse effects of chemotherapy regimens of 5-fluoropyrimidines derivatives and their association with DPYD polymorphisms in colorectal cancer patients. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-06904-3
|
| 21 |
Xiaolai Yang, Jian Zou, Hongyi Cai, Xiaoling Huang, Xiongfei Yang, Dexi Guo, Yongxiao Cao. Ginsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C/EBPβ/NF-κB signaling. Biomedicine & Pharmacotherapy 2017; 96: 1240 doi: 10.1016/j.biopha.2017.11.092
|
| 22 |
Luyao Zhang, Bo Li, Beilin Zhang, Hua Zhang, Jian Suo. miR‑361 enhances sensitivity to 5‑fluorouracil by targeting the FOXM1‑ABCC5/10 signaling pathway in colorectal cancer . Oncology Letters 2019; doi: 10.3892/ol.2019.10741
|
| 23 |
Pharmacological Inhibition of TFF3 Enhances Sensitivity of CMS4 Colorectal Carcinoma to 5-Fluorouracil through Inhibition of p44/42 MAPK. International Journal of Molecular Sciences 2019; 20(24): 6215 doi: 10.3390/ijms20246215
|
| 24 |
Shamin Azwar, Heng Fong Seow, Maha Abdullah, Mohd Faisal Jabar, Norhafizah Mohtarrudin. Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment. Biology 2021; 10(9): 854 doi: 10.3390/biology10090854
|
| 25 |
Gabriel Cutshaw, Nora Hassan, Saji Uthaman, Xiaona Wen, Bhuminder Singh, Anwesha Sarkar, Rizia Bardhan. Monitoring Metabolic Changes in Response to Chemotherapies in Cancer with Raman Spectroscopy and Metabolomics. Analytical Chemistry 2023; 95(35): 13172 doi: 10.1021/acs.analchem.3c02073
|
| 26 |
Peter F. Favreau, Jiaye He, Daniel A. Gil, Dustin A. Deming, Jan Huisken, Melissa C. Skala. Label-free redox imaging of patient-derived organoids using selective plane illumination microscopy. Biomedical Optics Express 2020; 11(5): 2591 doi: 10.1364/BOE.389164
|
| 27 |
Viktor Hlavac, Maria Kovacova, Katerina Elsnerova, Veronika Brynychova, Renata Kozevnikovova, Karel Raus, Katerina Kopeckova, Sona Mestakova, David Vrana, Jiri Gatek, Pavel Ostasov, Radka Vaclavikova, Pavel Soucek. Use of Germline Genetic Variability for Prediction of Chemoresistance and Prognosis of Breast Cancer Patients. Cancers 2018; 10(12): 511 doi: 10.3390/cancers10120511
|
| 28 |
Axel Grothey, Takayuki Yoshino, Gyorgy Bodoky, Tudor Ciuleanu, Rocio Garcia-Carbonero, Pilar García-Alfonso, Eric Van Cutsem, Kei Muro, Daniel S Mytelka, Li Li, Olga Lipkovich, Yanzhi Hsu, Andreas Sashegyi, David Ferry, Federico Nasroulah, Josep Tabernero. Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set. ESMO Open 2018; 3(3): e000347 doi: 10.1136/esmoopen-2018-000347
|
| 29 |
William H. Gmeiner. Fluoropyrimidine Modulation of the Anti-Tumor Immune Response―Prospects for Improved Colorectal Cancer Treatment. Cancers 2020; 12(6): 1641 doi: 10.3390/cancers12061641
|
| 30 |
Hung-Hsin Lin, Nien-Chih Wei, Teh-Ying Chou, Chun-Chi Lin, Yuan-Tsu Lan, Shin-Ching Chang, Huann-Sheng Wang, Shung-Haur Yang, Wei-Shone Chen, Tzu-Chen Lin, Jen-Kou Lin, Jeng-Kai Jiang. Building personalized treatment plans for early-stage colorectal cancer patients. Oncotarget 2017; 8(8): 13805 doi: 10.18632/oncotarget.14638
|
| 31 |
Thoranin Intarajak, Wandee Udomchaiprasertkul, Chakrit Bunyoo, Jutamas Yimnoon, Kamonwan Soonklang, Kriangpol Wiriyaukaradecha, Wisut Lamlertthon, Thaniya Sricharunrat, Worawit Chaiwiriyawong, Bunchorn Siriphongpreeda, Sawannee Sutheeworapong, Kanthida Kusonmano, Weerayuth Kittichotirat, Chinae Thammarongtham, Piroon Jenjaroenpun, Thidathip Wongsurawat, Intawat Nookaew, Chirayu Auewarakul, Supapon Cheevadhanarak. Genetic Aberration Analysis in Thai Colorectal Adenoma and Early-Stage Adenocarcinoma Patients by Whole-Exome Sequencing. Cancers 2019; 11(7): 977 doi: 10.3390/cancers11070977
|
| 32 |
Litaty Céphanoée Mbatchi, Jacques Robert, Marc Ychou, Jean-Christophe Boyer, Maguy Del Rio, Matthieu Gassiot, Fabienne Thomas, Nicole Tubiana, Alexandre Evrard. Effect of Single Nucleotide Polymorphisms in the Xenobiotic-sensing Receptors NR1I2 and NR1I3 on the Pharmacokinetics and Toxicity of Irinotecan in Colorectal Cancer Patients. Clinical Pharmacokinetics 2016; 55(9): 1145 doi: 10.1007/s40262-016-0392-5
|
| 33 |
Jacinta O. Pinho, Inês V. da Silva, Joana D. Amaral, Cecília M.P. Rodrigues, Angela Casini, Graça Soveral, M. Manuela Gaspar. Therapeutic potential of a copper complex loaded in pH-sensitive long circulating liposomes for colon cancer management. International Journal of Pharmaceutics 2021; 599: 120463 doi: 10.1016/j.ijpharm.2021.120463
|
| 34 |
Yongjun Zhang, Shuguang Guo, Jian Fang, Bojian Peng, Yuan Zhang, Tiansheng Cao. Tanshinone IIA inhibits cell proliferation and tumor growth by downregulating STAT3 in human gastric cancer. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6562
|
| 35 |
Erika Cecchin, Elena De Mattia, Fabrizio Ecca, Giuseppe Toffoli. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation. Drug Resistance Updates 2018; 39: 18 doi: 10.1016/j.drup.2018.07.001
|
| 36 |
Ching-Wei Chang, Hung-Chang Lee, Li-Hui Li, Jen-Shiu Chiang Chiau, Tsang-En Wang, Wei-Hung Chuang, Ming-Jen Chen, Horng-Yuan Wang, Shou-Chuan Shih, Chia-Yuan Liu, Tung-Hu Tsai, Yu-Jen Chen. Fecal Microbiota Transplantation Prevents Intestinal Injury, Upregulation of Toll-Like Receptors, and 5-Fluorouracil/Oxaliplatin-Induced Toxicity in Colorectal Cancer. International Journal of Molecular Sciences 2020; 21(2): 386 doi: 10.3390/ijms21020386
|
| 37 |
Morena Fasano, Alessio Fabozzi, Guido Giordano, Filippo Venturini, Gaetano Aurilio, Flavia Cantile, Teresa Fabozzi, Vincenzo Ricci, Giuseppe Santabarbara, Floriana Morgillo, Fortunato Ciardiello, Ferdinando De Vita. Complete response to capecitabine in a frail, elderly patient with metastatic colorectal cancer: A case report. Oncology Letters 2017; 13(2): 979 doi: 10.3892/ol.2016.5523
|
| 38 |
Dong Ju Son, Ji Eun Hong, Jung Ok Ban, Ju Ho Park, Hye Lim Lee, Sun Mi Gu, Jae Yeon Hwang, Myung Hee Jung, Dong Won Lee, Sang-Bae Han, Jin Tae Hong. Synergistic Inhibitory Effects of Cetuximab and Cisplatin on Human Colon Cancer Cell GrowthviaInhibition of the ERK-Dependent EGF Receptor Signaling Pathway. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/397563
|
| 39 |
Ragaa A Ramadan, Thanaa F Moghazy, Radwa Hafez, Heba Morsi, Mohamed Samir, Mohamed Shamesya. Significance of expression of pyrimidine metabolizing genes in colon cancer. Arab Journal of Gastroenterology 2020; 21(3): 189 doi: 10.1016/j.ajg.2020.07.006
|
| 40 |
Hira Choudhury, Manisha Pandey, Vilashini Saravanan, Amanda Tan Yee Mun, Subrat Kumar Bhattamisra, Ankit Parikh, Sanjay Garg, Bapi Gorain. Recent progress of targeted nanocarriers in diagnostic, therapeutic, and theranostic applications in colorectal cancer. Biomaterials Advances 2023; 153: 213556 doi: 10.1016/j.bioadv.2023.213556
|
| 41 |
Nurul-Syakima Ab Mutalib, Najwa F. Md Yusof, Shafina-Nadiawati Abdul, Rahman Jamal. Pharmacogenomics DNA Biomarkers in Colorectal Cancer: Current Update. Frontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00736
|
| 42 |
Ning Liu, Fengping Shan, Mingxing Ma. Strategic enhancement of immune checkpoint inhibition in refractory Colorectal Cancer: Trends and future prospective. International Immunopharmacology 2021; 99: 108017 doi: 10.1016/j.intimp.2021.108017
|
| 43 |
Ching-Wei Chang, Chia-Yuan Liu, Hung-Chang Lee, Yen-Hua Huang, Li-Hui Li, Jen-Shiu Chiang Chiau, Tsang-En Wang, Cheng-Hsin Chu, Shou-Chuan Shih, Tung-Hu Tsai, Yu-Jen Chen. Lactobacillus casei Variety rhamnosus Probiotic Preventively Attenuates 5-Fluorouracil/Oxaliplatin-Induced Intestinal Injury in a Syngeneic Colorectal Cancer Model. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.00983
|
| 44 |
Yanmei Zhang, Mengdie Fang, Yongfei Song, Juan Ren, Jianfei Fang, Xiaoju Wang. Brother of Regulator of Imprinted Sites (BORIS) suppresses apoptosis in colorectal cancer. Scientific Reports 2017; 7(1) doi: 10.1038/srep40786
|
| 45 |
Annie Cristhine Moraes Sousa-Squiavinato, Diego Alfonso Arregui Ramos, Mônica Silveira Wagner, Josiane Weber Tessmann, Julio Cesar Madureira de-Freitas-Junior, Jose Andrés Morgado-Díaz. Long-term resistance to 5-fluorouracil promotes epithelial–mesenchymal transition, apoptosis evasion, autophagy, and reduced proliferation rate in colon cancer cells. European Journal of Pharmacology 2022; 933: 175253 doi: 10.1016/j.ejphar.2022.175253
|
| 46 |
Mohammed Faruk, Sani Ibrahim, Surajo Mohammed Aminu, Ahmed Adamu, Adamu Abdullahi, Aishatu Maude Suleiman, Abdulmumini Hassan Rafindadi, Abdullahi Mohammed, Yawale Iliyasu, John Idoko, Rakiya Saidu, Abdullahi Jibril Randawa, Halimatu Sadiya Musa, Atara Ntekim, Khalid Zahir Shah, Sani Abubakar, Kasimu Umar Adoke, Muhammad Manko, Cheh Agustin Awasum, Irina V. Lebedeva. Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin. PLOS ONE 2021; 16(1): e0245581 doi: 10.1371/journal.pone.0245581
|
| 47 |
Adrien Guilloteau, Michal Abrahamowicz, Olayide Boussari, Valérie Jooste, Thomas Aparicio, Catherine Quantin, Karine Le Malicot, Christine Binquet. Impact of time-varying cumulative bevacizumab exposures on survival: re-analysis of data from randomized clinical trial in patients with metastatic colo-rectal cancer. BMC Medical Research Methodology 2021; 21(1) doi: 10.1186/s12874-020-01202-9
|
| 48 |
Loredana Salerno, Antonietta Notaro, Valeria Consoli, Federica Affranchi, Valeria Pittalà, Valeria Sorrenti, Luca Vanella, Michela Giuliano, Sebastiano Intagliata. Evaluation of the anticancer effects exerted by 5-fluorouracil and heme oxygenase-1 inhibitor hybrids in HTC116 colorectal cancer cells. Journal of Enzyme Inhibition and Medicinal Chemistry 2024; 39(1) doi: 10.1080/14756366.2024.2337191
|
| 49 |
RWK Wu, CMN Yow, Eric Law, ESM Chu, Zheng Huang. Effect of Foslip® mediated photodynamic therapy on 5-fluorouracil resistant human colorectal cancer cells. Photodiagnosis and Photodynamic Therapy 2020; 31: 101945 doi: 10.1016/j.pdpdt.2020.101945
|
| 50 |
Tung Hoang, Jeongseon Kim. Combining Correlated Outcomes and Surrogate Endpoints in a Network Meta-Analysis of Colorectal Cancer Treatments. Cancers 2020; 12(9): 2663 doi: 10.3390/cancers12092663
|